查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1571707

皮下避孕植入市場規模、佔有率、趨勢分析報告：按產品、通路、地區、細分市場預測，2024-2030 年

Subdermal Contraceptive Implants Market Size, Share & Trends Analysis Report By Product (Etonogestrel Implant, Levonorgestrel Implant), By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 80 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

皮下避孕植入市場成長與趨勢：

根據Grand View Research, Inc.最新報告，預計到2030年，全球皮下埋植避孕植入市場規模將達17.4億美元，2024年至2030年複合年成長率為7.5%。

市面上多種現代避孕藥具的採用、人們對各種避孕方法的認知不斷提高以及人均收入高是推動避孕皮下植入市場的一些關鍵因素。

據古特馬赫研究所稱，2014 年約有 2,000 萬名婦女需要公共資助的避孕服務。據 CDC 稱，2017 年，美國約有 4,690 萬名女性至少使用一種避孕方法。皮下植入是女性長期避孕的選擇。用於避孕的皮下植入以聚合物膠囊或棒的形式插入皮下。黃體素以緩慢而穩定的速度釋放，可提供 1 至 5 年的有效避孕作用。

公共資助的計劃生育服務幫助婦女避免或計劃懷孕。 2012 年，南卡羅來納州衛生與公眾服務部 (SCDHHS) 修訂了產後立即植入長效可逆避孕藥 (LARC) 的醫療補助支付政策。根據這項新的付款政策，除了診斷相關群組 (DRG) 之外，醫療服務提供者還可以使用帶有計劃生育修飾符的 J 代碼來對插入程序和子宮內避孕器或植入申請。

植入是撒哈拉以南非洲地區女性最廣泛使用的避孕方法。這要歸功於製造商、捐助者、政府和國際組織之間的官民合作關係關係，這有助於降低商品成本並提高產品可用性。南非、馬拉威和盧安達的避孕器使用率正在增加。根據 PLOS.org 報導，2016 年馬拉威長效可逆避孕藥 (LARC) 使用率在都市區達到 10.21%，在農村地區達到 9.66%。 2012年，啟動了一項名為「2020年計劃生育」（FP2020）的計劃，以確保到2020年1.2億婦女能夠獲得現代避孕方法。

皮下避孕植入市場報告亮點

  • 2023年，北美佔據避孕皮下植入市場的最大佔有率。這是由於意外懷孕的增加、政府支持避孕舉措的增加以及未滿足的需求不斷增加所致。
  • 中國、印度和新加坡等國家強勁的經濟成長、避孕和性傳染感染意識的提高以及可支配收入的增加預計將在未來幾年推動亞太市場的發展。
  • 人口快速成長是撒哈拉以南非洲國家面臨的主要問題，預計2050年該地區人口成長將佔世界人口成長的一半以上。這可能對皮下植入避孕藥的吸收產生正面影響。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章皮下植入市場變數、趨勢與範圍

  • 市場介紹/系統展望
  • 市場規模及成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 皮下植入避孕藥市場分析工具
    • 波特的分析
    • PESTEL分析

第4章皮下避孕植入市場：產品估算與趨勢分析

  • 細分儀表板
  • 皮下避孕植入市場：產品變化分析，百萬美元，2023-2030
  • 依托孕烯植入
  • levonorgestrel植入

第5章皮下避孕植入市場：通路估算及趨勢分析

  • 細分儀表板
  • 皮下避孕植入市場：通路波動分析，百萬美元，2023 年和 2030 年
  • 醫院
  • 婦科門診
  • 社區健康服務中心
  • 其他

第6章皮下避孕植入市場：區域估計與趨勢分析

  • 2023年及2030年皮下植入避孕藥市場佔有率（按地區）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭格局

  • 最新趨勢與影響分析：主要市場參與企業
  • 公司分類
  • 企業熱力圖分析
  • 公司簡介
    • Bayer AG
    • Merck &Co., Inc.
    • Shanghai Dahua Pharmaceutical Co.
簡介目錄
Product Code: GVR-3-68038-848-0

Subdermal Contraceptive Implants Market Growth & Trends:

The global subdermal contraceptive implants market size is expected to reach USD 1.74 billion by 2030, registering a CAGR of 7.5% from 2024 to 2030, according to a new report by Grand View Research, Inc. Introduction of several modern contraceptives in the market, growing awareness about various birth control methods, and high per capita income are some of the key factors driving the market for subdermal implants for birth control.

According to the Guttmacher Institute, in 2014, approximately 20 million women needed publicly funded contraceptive services. According to CDC, in 2017, nearly 46.9 million women in the U.S. were using at least one method of contraception. Subdermal implant is a long-term birth control option for women. Subdermal implants for contraception are in the form of polymer capsules or rods placed under the skin. The progestational hormone is released at a slow and stable rate, providing effective contraception for 1-5 years.

Publicly funded family planning services help women avoid or plan pregnancies. In 2012, the South Carolina Department of Health and Human Services (SCDHHS) revised the cost associated with Medicaid payment policy for immediate postpartum insertion of Long-Acting Reversible Contraception (LARC). Under this new reimbursement policy, providers are allowed to bill for the insertion procedure and the cost of an IUD or an implant, in addition to the Diagnosis Related Group (DRG) by using J-codes with a family planning modifier.

Implants are the most widely used contraceptive methods by women in sub-Saharan Africa owing to public-private partnerships between manufacturers, donors, governments, and international agencies, which helps lower commodity cost and increase product availability. Contraceptive usage has increased in South Africa, Malawi, and Rwanda. According to PLOS.org, in Malawi, the use of the Long-acting Reversible Contraception (LARC) method reached 10.21% in urban areas in 2016 and 9.66% in rural areas. In 2012, an initiative called Family Planning 2020 (FP2020) was launched to give 120 million women access to modern contraceptive methods by 2020.

Subdermal Contraceptive Implants Market Report Highlights:

  • North America held the maximum share in the market for subdermal implants for contraception in 2023. This can be attributed to growing number of unwanted pregnancies, increased government initiatives in favor of contraception, and rising unmet needs
  • Strong economic growth in countries such as China, India, and Singapore, increasing awareness about contraceptives and STIs, and rising disposable income are expected to boost the Asia Pacific market in the coming years
  • Rapid population growth is a major concern in sub-Saharan African countries; the region's population growth is projected to account for more than half of the global population growth by 2050. This could have a positive impact on the uptake of subdermal implants for birth control

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Subdermal Contraceptive Implants Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Subdermal Contraceptive Implants Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Subdermal Contraceptive Implants Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Subdermal Contraceptive Implants Market: Product Movement Analysis, USD Million, 2023 & 2030
  • 4.3. Etonogestrel Implant
    • 4.3.1. Etonogestrel Implant Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Levonorgestrel Implant
    • 4.4.1. Levonorgestrel Implant Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Subdermal Contraceptive Implants Market: Distribution Channel Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Subdermal Contraceptive Implants Market: Distribution Channel Movement Analysis, USD Million, 2023 & 2030
  • 5.3. Hospital
    • 5.3.1. Hospital Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Gynecology Clinics
    • 5.4.1. Gynecology Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Community Health Care Centres
    • 5.5.1. Community Health Care Centres Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Subdermal Contraceptive Implants Market: Regional Estimates & Trend Analysis

  • 6.1. Subdermal Contraceptive Implants Market Share, By Region, 2023 & 2030, (USD Million)
  • 6.2. North America
    • 6.2.1. North America Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Canada Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. UK Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Germany Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. France Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Italy Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Spain Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Denmark Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Sweden Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Norway Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. Japan
      • 6.4.2.1. Japan Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. China
      • 6.4.3.1. China Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. India Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. Australia
      • 6.4.5.1. Australia Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.6. South Korea
      • 6.4.6.1. South Korea Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.7. Thailand
      • 6.4.7.1. Thailand Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Argentina Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.5.3.2.
  • 6.6. Middle East and Africa
    • 6.6.1. Middle East and Africa Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. South Africa Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Saudi Arabia Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. UAE
      • 6.6.4.1. UAE Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Kuwait Subdermal Contraceptive Implants Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. Bayer AG
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/ Strategic Initiatives
    • 7.4.2. Merck & Co., Inc.
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/ Strategic Initiatives
    • 7.4.3. Shanghai Dahua Pharmaceutical Co.
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/ Strategic Initiatives